Merck KGaA of Germany has acquired all the shares in the six companiesof the Faust Group through its subsidiary Bender & Hobein. Merck previously had a minority participation in four of the companies in the Faust Group, which is focused on laboratory supplies and achieved turnover in 1996 of 92 million Deutschemarks ($53.9 million).
Merck notes that Germany's Federal Cartel Office has opposed its plans to acquire KMF, also in the laboratory chemicals field, and says that both itself and KMF intend to appeal against the FCO's decision.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze